GGrantIndex
← Leaderboards

Quiver Bioscience Inc.

Cambridge, MA

Compare ↔
$13,273,621
Total funding
7
Grants

Funding over time

peak $4.1M · FY201925
$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,273,621 · 7

By mechanism

R44$13,273,621 · 7

Investigators at Quiver Bioscience Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Largest grants

BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning$1,721,943
R44 · FY2023 · MH
BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning$1,278,054
R44 · FY2024 · MH
Ultra-high-throughput plate reader for drug discovery using all-optical electrophysiology$1,228,439
R44 · FY2022 · NS
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets$1,000,001
R44 · FY2021 · CA
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets$995,305
R44 · FY2022 · CA
A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling$995,203
R44 · FY2022 · MH
Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology$961,962
R44 · FY2023 · NS
A phenotypic screen for osteoarthritic pain therapeutics using all-optical electrophysiology.$892,810
R44 · FY2020 · AR
Safe-OPTION: Optical Physiology To Interrogate Oligonucleotide Neurotoxicity$862,420
R44 · FY2025 · NS
Functional drug fingerprinting with all-optical electrophysiology$793,383
R44 · FY2023 · MH
A phenotypic screen for osteoarthritic pain therapeutics using all-optical electrophysiology.$696,518
R44 · FY2021 · AR
A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling$635,498
R44 · FY2023 · MH
Functional drug fingerprinting with all-optical electrophysiology$378,127
R44 · FY2024 · MH
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets$300,728
R44 · FY2020 · CA
Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology$251,085
R44 · FY2024 · NS
A phenotypic screen for osteoarthritic pain therapeutics using all-optical electrophysiology.$230,695
R44 · FY2019 · AR
Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology$51,450
R44 · FY2025 · NS